After Jumping 5.18% During The Past Week, Should You Still Buy Pyxis Oncology Inc (NASDAQ: PYXS)?
Pyxis Oncology Inc (NASDAQ:PYXS)’s traded shares stood at 0.3 million during the last session, with the company’s beta value hitting 1.15. At the close of